Einar M Sigurdsson
NIH Rank #1647
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6107895Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Psychiatry
NIH Funding · FY2026
Linked Award Amount
$2.4M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#1,647
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Einar M Sigurdsson as a PI. Multi-PI records show the full award amount for context.
- 1U01AG098785-01U01Drug development of single domain antibodies to treat dementias with synucleinopathy$1.1Maward amount
- $677.7Kaward amount
- $677.3Kaward amount
Award organization
Organizations that administered FY2026 awards listing Einar M Sigurdsson as a PI.
FY2026 award administered by NYU Grossman School of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNYU Grossman School of Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4647
- 2024Entered Top 25% NationallyRanked #4647
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
- 2026Entered Top 10% NationallyRanked #1647
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Einar M Sigurdsson.